Chronic kidney disease (CKD) is a major public health issue, and kidney transplantation is the most effective treatment for end-stage renal disease. However, the long-term success of kidney transplantation is often hindered by chronic allograft dysfunction (CAD), which is characterized by progressive fibrosis in the transplanted kidney. Understanding the molecular mechanisms underlying CAD is crucial for improving transplant outcomes.

To be continued…